PTC Therapeutics Inc (NAS:PTCT)
$ 36.53 3.23 (9.7%) Market Cap: 2.80 Bil Enterprise Value: 2.34 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

PTC Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 03:30PM GMT
Release Date Price: $41.6 (+5.77%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Good morning, and welcome to the 41st Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. And let me just say how thrilled I am to be back here in person with you all to host this conference the best week of the year.

I'm looking forward to what I expect to be an exciting slate of presentations and I expect also constructive discussions over the course of the week. Our first presenting company is PTC Therapeutics, and presenting on behalf of the company is Chief Operating Officer, Matt Klein.

Before I hand it over, I just want to say -- sorry, I just want to note that we're going to be doing Q&A after the presentation in the room here. There will be mic runners. So just raise your hand if you have a question. You can also submit questions via the digital conference book, and I can work them in where appropriate.

So with that, Matt, thank you.

Matthew B. Klein
PTC Therapeutics, Inc. - COO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot